Home
/
BIO-TECHNE Corp
/
Financials
/
Quarterly
BIO-TECHNE Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIO-TECHNE Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$295.88M
Feb 4, 2026
Q1
2026
Sep 30, 2025
$286.56M
Nov 5, 2025
Q2
2026
Dec 31, 2024
$297.03M
Feb 4, 2026
Q1
2026
Sep 30, 2024
$289.46M
Nov 5, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$295.88M
Feb 4, 2026
Q1
2026
Sep 30, 2025
$286.56M
Nov 5, 2025
Q3
2025
Mar 31, 2025
$316.18M
May 8, 2025
Q2
2026
Dec 31, 2024
$297.03M
Feb 4, 2026
Q1
2026
Sep 30, 2024
$289.46M
Nov 5, 2025
Q3
2025
Mar 31, 2024
$303.43M
May 8, 2025
Q2
2025
Dec 31, 2023
$272.60M
Feb 6, 2025
Q1
2025
Sep 30, 2023
$276.94M
Nov 5, 2024
Q3
2024
Mar 31, 2023
$294.15M
May 6, 2024
Q2
2024
Dec 31, 2022
$271.58M
Feb 7, 2024
Q1
2024
Sep 30, 2022
$269.66M
Nov 7, 2023
Q3
2023
Mar 31, 2022
$290.38M
May 8, 2023
Q2
2023
Dec 31, 2021
$269.28M
Feb 7, 2023
Q1
2023
Sep 30, 2021
$257.72M
Nov 7, 2022
Q3
2022
Mar 31, 2021
$243.55M
May 9, 2022
Q2
2022
Dec 31, 2020
$224.25M
Feb 7, 2022
Q1
2022
Sep 30, 2020
$204.20M
Nov 8, 2021
Q3
2021
Mar 31, 2020
$194.68M
May 7, 2021
Q2
2021
Dec 31, 2019
$184.93M
Feb 8, 2021
Q1
2021
Sep 30, 2019
$183.24M
Nov 9, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Dec 31, 2017
$154.15M
Feb 8, 2018
Q1
2018
Sep 30, 2017
$144.61M
Nov 9, 2017
Q3
2017
Mar 31, 2017
$144.04M
May 10, 2017
Q2
2018
Dec 31, 2016
$131.81M
Feb 8, 2018
Q1
2018
Sep 30, 2016
$130.58M
Nov 9, 2017
Q3
2017
Mar 31, 2016
$130.97M
May 10, 2017
Q2
2017
Dec 31, 2015
$120.91M
Feb 9, 2017
Q1
2017
Sep 30, 2015
$112.38M
Nov 9, 2016
Q3
2016
Mar 31, 2015
$114.16M
May 10, 2016
Q2
2016
Dec 31, 2014
$111.95M
Feb 9, 2016
Q1
2016
Sep 30, 2014
$108.48M
Nov 9, 2015
Q3
2015
Mar 31, 2014
$95.56M
May 11, 2015
Q2
2015
Dec 31, 2013
$84.02M
Feb 9, 2015
Q1
2015
Sep 30, 2013
$85.67M
Nov 10, 2014
Q3
2014
Mar 31, 2013
$80.99M
May 12, 2014
Q2
2014
Dec 31, 2012
$75.08M
Feb 4, 2014
Q1
2014
Sep 30, 2012
$75.03M
Nov 12, 2013
Q3
2013
Mar 31, 2012
$83.62M
May 10, 2013
Q2
2013
Dec 31, 2011
$74.66M
Feb 11, 2013
Q1
2013
Sep 30, 2011
$77.60M
Nov 9, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$38.01M
Feb 4, 2026
Q1
2026
Sep 30, 2025
$38.19M
Nov 5, 2025
Q3
2025
Mar 31, 2025
$22.59M
May 8, 2025
Q2
2026
Dec 31, 2024
$34.89M
Feb 4, 2026
Q1
2026
Sep 30, 2024
$33.60M
Nov 5, 2025
Q3
2025
Mar 31, 2024
$49.06M
May 8, 2025
Q2
2025
Dec 31, 2023
$27.47M
Feb 6, 2025
Q1
2025
Sep 30, 2023
$50.99M
Nov 5, 2024
Q3
2024
Mar 31, 2023
$70.22M
May 6, 2024
Q2
2024
Dec 31, 2022
$50.01M
Feb 7, 2024
Q1
2024
Sep 30, 2022
$89.56M
Nov 7, 2023
Q3
2023
Mar 31, 2022
$60.74M
May 8, 2023
Q2
2023
Dec 31, 2021
$80.17M
Feb 7, 2023
Q1
2023
Sep 30, 2021
$69.62M
Nov 7, 2022
Q3
2022
Mar 31, 2021
$45.78M
May 9, 2022
Q2
2022
Dec 31, 2020
$46.27M
Feb 7, 2022
Q1
2022
Sep 30, 2020
$33.40M
Nov 8, 2021
Q3
2021
Mar 31, 2020
$36.43M
May 7, 2021
Q3
2020
Dec 31, 2019
$119.62M
May 11, 2020
Q2
2021
Dec 31, 2019
$119.62M
Feb 8, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$54.46M
Feb 4, 2026
Q1
2026
Sep 30, 2025
$47.66M
Nov 5, 2025
Q3
2025
Mar 31, 2025
$38.71M
May 8, 2025
Q2
2026
Dec 31, 2024
$47.42M
Feb 4, 2026
Q1
2026
Sep 30, 2024
$39.99M
Nov 5, 2025
Q3
2025
Mar 31, 2024
$67.00M
May 8, 2025
Q2
2025
Dec 31, 2023
$38.00M
Feb 6, 2025
Q1
2025
Sep 30, 2023
$55.86M
Nov 5, 2024
Q3
2024
Mar 31, 2023
$80.21M
May 6, 2024
Q2
2024
Dec 31, 2022
$67.89M
Feb 7, 2024
Q1
2024
Sep 30, 2022
$56.32M
Nov 7, 2023
Q3
2023
Mar 31, 2022
$90.45M
May 8, 2023
Q2
2023
Dec 31, 2021
$62.35M
Feb 7, 2023
Q1
2023
Sep 30, 2021
$63.22M
Nov 7, 2022
Q3
2022
Mar 31, 2021
$68.63M
May 9, 2022
Q2
2022
Dec 31, 2020
$51.00M
Feb 7, 2022
Q1
2022
Sep 30, 2020
$49.09M
Nov 8, 2021
Q3
2021
Mar 31, 2020
$47.79M
May 7, 2021
Q2
2021
Dec 31, 2019
$36.99M
Feb 8, 2021
Q1
2021
Sep 30, 2019
$33.33M
Nov 9, 2020